Collectively, our preclinical data highlight the critical role of the TGF-β/PGE2 cytokine balance in regulating DC maturation, migration, and DC-T cell activation within the post-RT TME, ultimately leading to tumor shrinkage. The gene discussed is TGFB1; the disease is neoplasm.